← Open Payments lookup

JORGE RIVERA-COLON: Open Payments

NPI 1396951414 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$433 in 19 payments from 6 companies in 2025. Trend: 2023 $193 · 2024 $96 · 2025 $433

Food & beverage: $433
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.7$144
Janssen Pharmaceuticals, Inc3$109
ABBVIE INC.5$93
Alkermes, Inc.2$43
Teva Pharmaceuticals USA, Inc.1$22
Takeda Pharmaceuticals U.S.A., Inc.1$21

Products named: INVEGA SUSTENNA, VRAYLAR, REXULTI, ABILIFY ASIMTUFII, ARISTADA, UZEDY, TRINTELLIX, LYBALVI.

Industry payments across PA — which companies pay providers there.